A METABOLITE OF PROGESTERONE 11-DEOXYCORTICOSTERONE IN PLACENTA DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION
https://doi.org/10.12737/article_5c89a8000f2931.69649220
Abstract
The aim of the work is to study the content of 11-deoxycorticosterone in the placenta during pregnancy complicated by exacerbation of cytomegalovirus infection. Histochemical method was used to determine the content of 11-deoxycorticosterone in 72 placentas, including 37 cases from women with acute cytomegalovirus infection and simultaneously diagnosed moderate preeclampsia, and 35 placentas from women with exacerbation of chronic cytomegalovirus infection without concomitant diseases. The control group consisted of 30 placentas from mothers with chronic cytomegalovirus infection in the latent stage. It was found out that an increase in the content of 11-deoxycorticosterone in placenta by 25% in comparison with the control group occurred during gestation with an exacerbation of cytomegalovirus infection. A significant increase (by 40%) in the content of this hormone in the placenta was noted during the reactivation of the viral process accompanied by preeclampsia. We believe that an increase in the production of 11-deoxycorticosterone with mineralocorticotropic effect in the placenta could contribute to the development of hypertensive disorders in pregnancy complicated by cytomegalovirus infection.
About the Authors
I. V. Dovzhikova
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
I. A. Andrievskaya
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
K. K. Petrova
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
N. А. Ishutina
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
I. N. Gorikov
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
References
1. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). М., 2016. 72 с.
2. Лойда З., Госсрау Р., Шиблер Т. Гистохимия ферментов. Лабораторные методы: пер. с англ. М.: Мир, 1982. 272 с.
3. Репина М.А., Бобров С. А. Значение прогестагенов для акушерской практики // Журнал акушерства и женских болезней. 2013. Т.62, Вып.3. С. 65-69.
4. Berger A., Doerr H.W. Preventing vertical virus infections: the role of serologic screening of pregnant women // Med. Microbiol. Immunol. 2018. Vol.207, №5-6. P.249-253. doi: 10.1007/s00430-018-0549-y
5. Casey M.L., Winkel C.A., Guerami A., MacDonald P.C. Mineralocorticosteroids and pregnancy: regulation of extra-adrenal deoxycorticosterone production by estrogen // J. Steroid Biochem. 1987. Vol.27, №4-6. Р.1013-1015.
6. Corsan G.H., MacDonald P.C., Casey M.L. Origin of deoxycorticosterone sulfate (DOC-SO4) in plasma of pregnant women: pregnenolone-3,21-disulfate is a placental precursor of DOC-SO4 // J. Steroid Biochem. Mol. Biol. 1997. Vol.60, №5-6. Р.331-337. doi:10.1016/S0960-0760(96)00224-5
7. Geraili Z., Riahi S.M., Khani S., Rostami A., Bayani M., Hajian-Tilaki K., Nourollahpour Shiadeh M. Cytomegalovirus infection and risk of preeclampsia: A meta-analysis of observational studies // Caspian J. Intern. Med. 2018. Vol.9, №3. Р.211-219. doi: 10.22088/cjim.9.3.211
8. Nourollahpour Shiadeh M., Behboodi Moghadam Z., Adam I., Saber V., Bagheri M., Rostami A. Human infectious diseases and risk of preeclampsia: an updated review of the literature // Infection. 2017. Vol.45, №5. Р.589-600. doi: 10.1007/s15010-017-1031-2
9. Pass R.F., Arav-Boger R. Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention // F1000Res. 2018. Vol.7. Р.255. doi: 10.12688/f1000research.12517.1
10. Vinson G.P. The mislabeling of deoxycorticosterone: making sense of corticosteroid structure and function // J. Endocrinol. 2011. Vol.211, №1. Р.3-16. doi: 10.1530/JOE-11-0178
11. Winkel C.A., Milewich L., Parker C.R. Jr., Gant N.F., Simpson E.R., MacDonald P.C. Conversion of plasma progesterone to deoxycorticosterone in men, nonpregnant and pregnant women, and adrenalectomized subjects // J. Clin. Invest. 1980. Vol.66, №4. Р.803-812.
12. Hypertensive disorders during pregnancy, during childbirth and the postpartum period. Pre-eclampsia. Eclampsia. Clinical guidelines (treatment protocol). Moscow; 2016 (in Russian).
13. Lojda Z., Gossrau R., Schiebler T.H. Enzyme histochemistry: a laboratory manual. Мoscow: Mir; 1982 (in Russian).
14. Repina M.A., Bobrov S.A. The role of progestogens in obstetrics practice Zhurnal akusherstva i zhenskikh bolezney 2013; 62(3):65-69 (in Russian).
15. Berger A., Doerr H.W. Preventing vertical virus infections: the role of serologic screening of pregnant women. Med. Microbiol. Immunol. 2018; 207(5-6):249-253. doi: 10.1007/s00430-018-0549-y
16. Casey M.L., Winkel C.A., Guerami A., MacDonald P.C. Mineralocorticosteroids and pregnancy: regulation of extra-adrenal deoxycorticosterone production by estrogen. J. Steroid Biochem. 1987; 27(4-6):1013-1015.
17. Corsan G.H., MacDonald P.C., Casey M.L. Origin of deoxycorticosterone sulfate (DOC-SO4) in plasma of pregnant women: pregnenolone-3,21-disulfate is a placental precursor of DOC-SO4. J. Steroid Biochem. Mol. Biol. 1997; 60(5-6):331-337. doi:10.1016/S0960-0760(96)00224-5
18. Geraili Z., Riahi S.M., Khani S., Rostami A., Bayani M., Hajian-Tilaki K., Nourollahpour Shiadeh M. Cytomegalovirus infection and risk of preeclampsia: A meta-analysis of observational studies. Caspian J. Intern. Med. 2018; 9(3):211-219. doi: 10.22088/cjim.9.3.211
19. Nourollahpour Shiadeh M., Behboodi Moghadam Z., Adam I., Saber V., Bagheri M., Rostami A. Human infectious diseases and risk of preeclampsia: an updated review of the literature. Infection 2017; 45(5):589-600. doi: 10.1007/s15010-017-1031-2
20. Pass R.F., Arav-Boger R. Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. F1000Res. 2018; 7:255. doi: 10.12688/f1000research.12517.1
21. Vinson G.P. The mislabeling of deoxycorticosterone: making sense of corticosteroid structure and function. J. Endocrinol. 2011; 211(1):3-16. doi: 10.1530/JOE-11-0178
22. Winkel C.A., Milewich L., Parker C.R. Jr., Gant N.F., Simpson E.R., MacDonald P.C. Conversion of plasma progesterone to deoxycorticosterone in men, nonpregnant and pregnant women, and adrenalectomized subjects. J. Clin. Invest. 1980; 66(4):803-812.
Review
For citations:
Dovzhikova I.V., Andrievskaya I.A., Petrova K.K., Ishutina N.А., Gorikov I.N. A METABOLITE OF PROGESTERONE 11-DEOXYCORTICOSTERONE IN PLACENTA DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION. Bulletin Physiology and Pathology of Respiration. 2019;(71):84-87. (In Russ.) https://doi.org/10.12737/article_5c89a8000f2931.69649220
Views:
132
Email this article 